Last reviewed · How we verify

NCT06651645

Pre- vs Post-Pandemic Risk-adjusted Survival Rates in the US Hospitals

Active, enrolled Last updated 29 April 2025
What this trial tests

trial testing COVID-19 Surge in In-hospital Mortality in 30,000,000 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
30 July 2024
Primary endpoint
30 June 2025
30 June 2025

Quick facts

Lead sponsorNational Institutes of Health Clinical Center (CC)
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment30,000,000
Start date30 July 2024
Primary completion30 June 2025
Estimated completion30 June 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

National Institutes of Health Clinical Center (CC)

Who can join

18 and older, any sex, with In-hospital Mortality or Non-COVID Deaths. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to perform a retrospective cohort study of administrative health data to understand how care delivery performance varies across US hospitals post-COVID-19 pandemic compared to the pre-pandemic performance. We also hope to identify which factors contribute to performance changes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other National Institutes of Health Clinical Center (CC) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06651645.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing